Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2776 AL 2790

Mechanisms of lysosomal tubulation and sorting driven by LRRK2

Bonet-Ponce L, Kluss JH, Cookson MR.

Biochem Soc Trans. 2024 Aug 28;52(4):1909-1919. doi: 10.1042/BST20240087.

White matter injury across neurodegenerative disease

Festa LK, Grinspan JB, Jordan-Sciutto KL.

Trends Neurosci. 2024 Jan;47(1):47-57. doi: 10.1016/j.tins.2023.11.003. Epub 2023 Dec 4.

COVID-19 related neurological manifestations in Parkinson's disease: has ferroptosis been a suspect?

Jia F, Han J.

Cell Death Discov. 2024 Mar 19;10(1):146. doi: 10.1038/s41420-024-01915-6.

Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson's Disease

Urmeneta-Ortíz MF, Tejeda-Martínez AR, González-Reynoso O, Flores-Soto ME.

Parkinsons Dis. 2024 Jul 25;2024:5519396. doi: 10.1155/2024/5519396. eCollection 2024.

Potential hypothesis for the increased risk of Parkinson´s disease following COVID-19

Mormile R, Mormile C, Picone C.

Mol Biol Rep. 2024 Oct 21;51(1):1085. doi: 10.1007/s11033-024-10021-w.

The Gut Microbiome as a Catalyst and Emerging Therapeutic Target for Parkinson's Disease: A Comprehensive Update

Kerstens R, Joyce P.

Biomedicines. 2024 Aug 2;12(8):1738. doi: 10.3390/biomedicines12081738.

Progressive supranuclear palsy, a case report

Ortiz A, Troya F, de Vera J, Vázquez E.

Arch Soc Esp Oftalmol (Engl Ed). 2024 Jul;99(7):304-308. doi: 10.1016/j.oftale.2024.05.004. Epub 2024 May 19.

The effects of cholesterol and statins on Parkinson's neuropathology: a narrative review

Al-Kuraishy HM, Fahad EH, Al-Windy S, El-Sherbeni SA, Negm WA, Batiha GE.

Inflammopharmacology. 2024 Apr;32(2):917-925. doi: 10.1007/s10787-023-01400-z. Epub 2024 Mar 18.

Therapeutic Targets of Probiotics in Parkinson Disease: A Systematic Review of Randomized Controlled Trials

Atak ES, Yıldız D, Kocatürk RR, Temizyürek A, Özcan ÖÖ, Ergüzel TT, Karahan M, Tarhan N.

Basic Clin Neurosci. 2024 Mar-Apr;15(2):165-174. doi: 10.32598/bcn.2022.3665.1. Epub 2024 Mar 1.

PET imaging of synaptic density in Parkinsonian disorders

Martin SL, Uribe C, Strafella AP.

J Neurosci Res. 2024 Mar;102(3):e25253. doi: 10.1002/jnr.25253. Epub 2023 Oct 10.

Eye movements in Parkinson's disease: from neurophysiological mechanisms to diagnostic tools

Antoniades CA, Spering M.

Trends Neurosci. 2024 Jan;47(1):71-83. doi: 10.1016/j.tins.2023.11.001. Epub 2023 Dec 2.

Air pollution and neurological diseases, current state highlights

Roy R, D'Angiulli A.

Front Neurosci. 2024 Mar 6;18:1351721. doi: 10.3389/fnins.2024.1351721. eCollection 2024.

Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine

Summers RA, Fagiani F, Rowitch DH, Absinta M, Reich DS.

Trends Immunol. 2024 Oct;45(10):799-813. doi: 10.1016/j.it.2024.08.004. Epub 2024 Sep 21.

The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer's and Parkinson's Diseases

Czarnik W, Fularski P, Gajewska A, Jakubowska P, Uszok Z, Młynarska E, Rysz J, Franczyk B.

Nutrients. 2024 Jan 19;16(2):308. doi: 10.3390/nu16020308.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias